Kidney cancer is one of the fastest-growing cancers in the U.S., and until recently, a diagnosis of advanced disease often ...
TipRanks on MSN
Exelixis and Merck advance LITESPARK-033: A new kidney cancer combo with high-stakes market potential
Exelixis ($EXEL) announced an update on their ongoing clinical study. Study Overview The LITESPARK-033 study, formally titled “A Phase 3, ...
Researchers have developed an AI-based tool that accelerates the detection of kidney cancer. Its effectiveness was validated ...
TipRanks on MSN
New Pumitamig kidney cancer trial adds long-term optionality for Bristol-Myers Squibb and BioNTech
Bristol Myers and BioNTech Advance Kidney Cancer Combo Study With New Early-Stage Trial ...
Cytoreductive nephrectomy merits further consideration in appropriately risk-stratified, surgically fit patients with mRCC.
Renal tumor pathology has evolved considerably, expanding from two main types of renal malignant tumors to over 20 distinct types. Diagnostic criteria have advanced from purely morphological features ...
Forbes contributors publish independent expert analyses and insights. I am a physician and behavioral scientist at Duke University. Most normal people, when told they have kidney cancer, worry about ...
Impact of Comprehensive Genome Profiling on the Management of Advanced Non–Small Cell Lung Cancer: Preliminary Results From the Lung Cancer Cohort of the FPG500 Program Consecutive patients who ...
TRENTON, New Jersey (WPVI) -- Surgery to remove a tumor from New Jersey Governor Phil Murphy's kidney was a success, the state's lieutenant governor said. Murphy is now resting at a hospital in New ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback